{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:50Z","timestamp":1791489710809,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jaip.2014.06.005","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T17:09:26Z","timestamp":1409332166000},"page":"741-750.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":214,"title":["High Blood Eosinophil Count Is a Risk Factor for Future Asthma Exacerbations in Adult Persistent Asthma"],"prefix":"10.1016","volume":"2","author":[{"given":"Robert S.","family":"Zeiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaowu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wansu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak B.","family":"Khatry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gossage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung N.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2014.06.005_bib1","unstructured":"Center for Disease Control and Prevention. Asthma. 2011. http:\/\/www.cdc.gov\/vitalsigns\/asthma. Accessed July 10, 2014."},{"key":"10.1016\/j.jaip.2014.06.005_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/17476348.2014.880052","article-title":"Biomarkers of eosinophilic inflammation in asthma","volume":"8","author":"Loutsios","year":"2014","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaip.2014.06.005_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2222.1985.tb02290.x","article-title":"Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions","volume":"15","author":"Durham","year":"1985","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaip.2014.06.005_bib4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/cea.12069","article-title":"Age-dependent interaction between atopy and eosinophils in asthma cases: results from NHANES 2005-2006","volume":"43","author":"Arbes","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2014.06.005_bib5","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1046\/j.1365-2222.1999.00667.x","article-title":"Serum eosinophilic cationic protein and blood eosinophil counts for the prediction of the presence of airways inflammation in children with wheezing","volume":"29","author":"Shields","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2014.06.005_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1183\/09031936.00201813","article-title":"Importance of concomitant local and systemic eosinophilia in uncontrolled asthma","volume":"44","author":"Schleich","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2014.06.005_bib7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1067\/mai.2001.114246","article-title":"Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal","volume":"107","author":"Lonnkvist","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.06.005_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaci.2013.09.002","article-title":"Childhood asthma clusters and response to therapy in clinical trials","volume":"133","author":"Chang","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2013.07.004","article-title":"Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis","volume":"133","author":"Bochenek","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1513\/AnnalsATS.201310-354OC","article-title":"Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma","volume":"11","author":"Katz","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2014.06.005_bib12","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.rmed.2013.07.014","article-title":"Phenotypic predictors of response to oral glucocorticosteroids in severe asthma","volume":"107","author":"Kupczyk","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2014.06.005_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaci.2013.02.032","article-title":"High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects","volume":"132","author":"Busse","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/thoraxjnl-2012-201876","article-title":"Key observations from the NHLBI Asthma Clinical Research Network","volume":"67","author":"Szefler","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2014.06.005_bib15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaci.2014.02.006","article-title":"Classification of childhood asthma phenotypes and long-term clinical response to inhaled anti-inflammatory medication","volume":"133","author":"Howrylak","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2004.11.014","article-title":"Characterization of within-subject responses to fluticasone and montelukast in childhood asthma","volume":"115","author":"Szefler","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaci.2008.12.1120","article-title":"Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma","volume":"123","author":"Bacharier","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa1001278","article-title":"Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids","volume":"362","author":"Lemanske","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2014.06.005_bib19","first-page":"650","article-title":"How well do the HEDIS asthma inclusion criteria identify persistent asthma?","volume":"11","author":"Mosen","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2014.06.005_bib20","first-page":"e281","article-title":"Persistent asthma defined using HEDIS versus survey criteria","volume":"16","author":"Schatz","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2014.06.005_bib21","first-page":"80","article-title":"Better asthma management with advanced technology: creation of an asthma utilization Rx analyzer (AURA) tool","volume":"34","author":"Jackson","year":"2009","journal-title":"P\u00a0T"},{"key":"10.1016\/j.jaip.2014.06.005_bib22","first-page":"478","article-title":"Development and validation of a medication intensity scale derived from computerized pharmacy data that predicts emergency hospital utilization for persistent asthma","volume":"12","author":"Schatz","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2014.06.005_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1378\/chest.130.1.43","article-title":"The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes","volume":"130","author":"Schatz","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2014.06.005_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1081-1206(10)60487-5","article-title":"Asthma quality-of-care measures using administrative data: relationships to subsequent exacerbations in multiple databases","volume":"101","author":"Schatz","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib25","first-page":"25","article-title":"Asthma population management: development and validation of a practical 3-level risk stratification scheme","volume":"10","author":"Schatz","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2014.06.005_bib26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaci.2006.01.053","article-title":"Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data","volume":"117","author":"Schatz","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1378\/chest.128.2.602","article-title":"Short-acting beta-agonist prescription fills as a marker for asthma morbidity","volume":"128","author":"Naureckas","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2014.06.005_bib28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1081-1206(10)60286-4","article-title":"Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations","volume":"101","author":"Paris","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib29","first-page":"19","article-title":"Relationship between short-acting beta2-adrenergic agonist use and healthcare costs","volume":"17","author":"Silver","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2014.06.005_bib30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.06.005_bib31","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2014.06.005_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaci.2011.06.008","article-title":"Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids","volume":"128","author":"Zeiger","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib33","first-page":"897","article-title":"Step-up care improves impairment in uncontrolled asthma: administrative data study","volume":"16","author":"Zeiger","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2014.06.005_bib34","unstructured":"Available from: http:\/\/www.qualitymeasures.ahrq.gov\/content.aspx?id=47173&search=Anti-Asthmatic+Agents. Accessed May 1, 2014."},{"issue":"Pt 1","key":"10.1016\/j.jaip.2014.06.005_bib35","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0091-6749(89)90391-6","article-title":"Blood eosinophils and eosinophil-derived proteins in allergic asthma","volume":"84","author":"Durham","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2006.09.042","article-title":"Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial","volume":"119","author":"Sorkness","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib37","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaci.2008.08.021","article-title":"Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children","volume":"122","author":"Covar","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib38","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2014.06.005_bib39","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","article-title":"Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study","volume":"184","author":"Castro","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.06.005_bib40","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2013.04.052","article-title":"Severe adult-onset asthma: a distinct phenotype","volume":"132","author":"Amelink","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anai.2014.04.011","article-title":"High blood eosinophil count is associated with more frequent asthma attacks in asthma patients","volume":"11","author":"Tran","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaci.2011.03.027","article-title":"Improving asthma outcomes in large populations","volume":"128","author":"Schatz","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/ACI.0b013e32835335ac","article-title":"Predictors of asthma control: what can we modify?","volume":"12","author":"Schatz","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib44","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jaip.2013.07.009","article-title":"Overweight\/obesity and risk of seasonal asthma exacerbations","volume":"1","author":"Schatz","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2014.06.005_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2466-8-27","article-title":"Identification and management of adults with asthma prone to exacerbations: can we do better?","volume":"8","author":"Thomson","year":"2008","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2014.06.005_bib46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.anai.2013.01.002","article-title":"Age-related differences in asthma outcomes in the United States, 1988-2006","volume":"110","author":"Tsai","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib47","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1378\/chest.128.4.1968","article-title":"Asthma quality-of-care markers using administrative data","volume":"128","author":"Schatz","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2014.06.005_bib48","article-title":"Use of health information technology to improve medication adherence","volume":"17","author":"Vollmer","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2014.06.005_bib49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2006.08.042","article-title":"Reliability and predictive validity of the Asthma Control Test administered by telephone calls using speech recognition technology","volume":"119","author":"Schatz","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib50","first-page":"206","article-title":"Asthma-specific quality of life and subsequent asthma emergency hospital care","volume":"14","author":"Schatz","year":"2008","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2014.06.005_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1067\/mai.2001.111590","article-title":"FEV(1) is associated with risk of asthma attacks in a pediatric population","volume":"107","author":"Fuhlbrigge","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/02770903.2010.539295","article-title":"Association of exhaled nitric oxide to asthma burden in asthmatics on inhaled corticosteroids","volume":"48","author":"Zeiger","year":"2011","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2014.06.005_bib53","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2003.08.014","article-title":"Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children","volume":"112","author":"Strunk","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib54","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1164\/ajrccm.164.5.2012125","article-title":"The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control","volume":"164","author":"Jones","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.06.005_bib55","unstructured":"Available from: https:\/\/physicians.prospectmedical.com\/physician\/PMS\/Secure\/p4p\/HEIDIS%20Section\/Educational%20Tools\/HEIDIS%20Measures\/Use%20of%20Appropriate%20Medications%20for%20People%20With%20Asthma%20(ASM).pdf. Accessed May 1, 2014."},{"key":"10.1016\/j.jaip.2014.06.005_bib56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaip.2014.01.018","article-title":"Real-time asthma outreach reduces excessive short-acting beta-agonist use: a randomized study","volume":"2","author":"Zeiger","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.jaip.2014.06.005_bib57","first-page":"650","article-title":"How well do the HEDIS asthma inclusion criteria identify persistent asthma?","volume":"11","author":"Mosen","year":"2005","journal-title":"Am J Manag Care"},{"issue":"4","key":"10.1016\/j.jaip.2014.06.005_bib59","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaci.2007.12.1178","article-title":"Asthma costs and utilization in a managed care organization","volume":"121","author":"Zeiger","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.005_bib60","first-page":"897","article-title":"Step-up Care Improves Impairment In Uncontrolled Asthma: Administrative Data Study","volume":"16","author":"Zeiger","year":"2010","journal-title":"Am J Manag. Care"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219814002633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219814002633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:07:43Z","timestamp":1761973663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219814002633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S2213219814002633"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2014.06.005","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Blood Eosinophil Count Is a Risk Factor for Future Asthma Exacerbations in Adult Persistent Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2014.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}